Hydroxyapatite-coated total hip replacement in Paget's disease: 20 patients followed for 4-8 years.
20 patients, who had had total hip replacements for symptomatic osteoarthrosis secondary to Paget's disease, were followed for a mean of 6 (4-8) years. Proximal hydroxyapatite-coated stems were implanted in all patients. 12 patients received hydroxyapatite-coated, 2 cemented (Muller type) and 6 cementless cups (Morsher type). The mean Harris hip score was 31 (7-40) points preoperatively and 88 (74-100) postoperatively. The radiographic evaluation revealed good stability and fixation using Engh's criteria. One stem subsided early more than 5 mm and then seemed to stabilize. Our findings support the use of hydroxyapatite total hip implants for patients with this disease and osteoarthrosis.
Kirsh
G
G
Department of Orthopaedics, St George Private Hospital, Sydney, Australia.
Kligman
M
M
Roffman
M
M
D000368:Aged; D000369:Aged, 80 and over; D019644:Arthroplasty, Replacement, Hip / Q000379:methods; D017886:Durapatite; D005260:Female; D005500:Follow-Up Studies; D006621:Hip Joint / Q000000981:diagnostic imaging / Q000601:surgery*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010001:Osteitis Deformans / Q000150:complications*; D010003:Osteoarthritis / Q000209:etiology / Q000601:surgery*; D011859:Radiography; D013997:Time Factors; D016896:Treatment Outcome
D017886:Durapatite